DNA Markets

DNA Markets, legally registered as Focus Markets Pty Ltd, is an Australian-based trading platform established on 29 November 2022. The company operates from its registered office at South Tower Level 35, 525 Collins Street, Melbourne, VIC 3000, Australia. It presents itself as a regulated trading venue under the Australian Securities and Investments Commission (ASIC), holding a Market Making (MM) licence.

According to our records, the broker offers access to a broad range of asset classes, including forex, commodities, shares, indices, and cryptocurrencies. The platform claims to provide fast trade execution and competitive pricing, with access to over 800 financial instruments. However, independent public information about the broker is limited, and we note that the company reports zero employees in our registry data.

DNA Markets is regulated by the Australian Securities and Investments Commission (ASIC), one of the most respected financial regulators globally. The licence on file is for Market Making (MM) activities, with licence number 514425, as recorded in our official records. This licence is registered in Australia, where the company is headquartered.

It is important to note that while ASIC regulation provides a level of oversight, the specific licence number is not published in our public-facing records. We recommend traders verify the licence directly with ASIC's public register to confirm its current status and any conditions attached.

DNA Markets advertises a diverse portfolio of trading instruments, spanning forex, commodities, shares, indices, and cryptocurrencies. This multi-asset offering is designed to cater to traders seeking exposure across different markets. The broker claims to provide access to over 800 financial instruments, which would position it as a comprehensive trading platform for retail clients.

However, the exact list of instruments, contract specifications, and trading conditions are not detailed in our known facts. Traders should consult the broker's official website for the most up-to-date information on available markets and trading hours.

Our records do not specify the account types or trading platforms offered by DNA Markets. Typically, retail forex brokers provide a range of account tiers, such as standard, mini, or ECN accounts, and support popular platforms like MetaTrader 4 or 5. However, without official confirmation, we cannot verify these details.

Given the lack of public information, we advise potential clients to contact the broker directly or review their website for specifics on account minimums, leverage, and platform compatibility. The absence of this information in our records is a point of caution for traders who rely on transparent disclosures.

Details regarding funding methods and withdrawal procedures for DNA Markets are not available in our known facts. The broker's website may offer various payment options, such as bank transfers, credit/debit cards, or e-wallets, but we cannot confirm these without official data.

Notably, our risk assessment flags that approximately 18% of recent reviews mention withdrawal complaints. This is a significant red flag that traders should weigh carefully. We strongly recommend verifying the broker's withdrawal policy and testing with a small deposit before committing larger funds.

DNA Markets was founded in late 2022 and began operations in 2023. The company is registered in Australia, and its official domain is dnamarkets.com. It maintains a presence on social media platforms including Facebook, Instagram, LinkedIn, and YouTube, which may serve as channels for updates and client engagement.

Our records indicate that one clone or impersonator site has been identified, which is a common risk in the forex industry. Traders should always verify that they are using the official domain and exercise caution against phishing attempts. The company reports zero employees, which is unusual for a broker and may warrant further investigation into its operational capacity.

In FXCanary's assessment, DNA Markets carries a Scam Risk Score of 36 out of 100, categorised as 'Guarded'. This score reflects a moderate level of risk, primarily driven by the withdrawal complaints mentioned earlier. While the ASIC licence provides a regulatory framework, the lack of independent reviews and limited public information makes it difficult to fully assess the broker's reliability.

We advise traders to approach DNA Markets with caution, conduct thorough due diligence, and consider starting with a minimal deposit to test the platform's execution and withdrawal processes. The presence of impersonator sites further underscores the need for vigilance when accessing the broker's services.